
Sunday, July 06, 2025 6:30:56 AM
My whole argument is that these tickers are thinly traded to begin with and people who trade Pinks know exactly what they are doing. I replied that I would be happy to sign a hold harmless agreement if that helps.
Again, I don't expect them to buckle but you never know. Squeaky wheel gets the grease?
Thank you for your reply - I'm happy to help!
We regret any inconvenience this policy will cause, and I will forward your feedback to our continuous improvement team for consideration. In the interim, I'm pleased to note that we do not charge broker assisted fees for 15c-2-11 trades that require broker placement. If you would like, you are also welcome to speak with our trade support desk directly regarding this SEC regulation, approach, and how soon it may drop the status if it is uplisted (at 800-435-4000 M-F until 5pm ET). Thank you for your understanding. We greatly appreciate your business.

Recent TGLO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2025 07:54:06 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2025 08:11:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2024 10:30:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2024 09:06:12 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM